PARSIPPANY, N.J. / Oct 10, 2023 / Business Wire / For the tenth year in a row, Zoetis, the world leader in animal health, has been named one of Seramount’s 100 Best Companies for Working Parents. The recognition reflects Zoetis’ commitment to providing a culture focused on colleagues’ careers, connection and support.
“Zoetis means something different to every one of our colleagues. But the one thing that unites us is our purpose of nurturing the world and humankind by advancing animal care,” said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Global Operations. “We believe that providing inclusive, family-friendly benefits and a flexible work environment helps all of our colleagues thrive and connect with our purpose on an individual level, impacting animal health every day. We are honored to once again be named one of Seramount’s 100 Best Companies for Working Parents.”
Mary Bradley Named Zoetis’ Working Mother of the Year
As part of the 100 Best Companies recognition, Zoetis named Mary Bradley its 2023 Working Mother of the Year. Head of Colleague Experience Communications and mother to Mitike, 17 and Atirsaw, 15, Mary joined Zoetis two years ago and in a short time, has made a significant impact on the company’s brand and culture by leading the development and implementation of the employer value proposition recruiting brand and senior leader engagement strategy. Additionally, Mary is very focused on supporting the development of future talent through the Zoetis Internship Program, introducing college students to the animal health industry as they consider a career in communications. Mary is also a pet parent, offering a loving home to seven senior rescue dogs. “As a working mom, and pet parent as well, I feel a true connection to our purpose at Zoetis, and I am so proud knowing that I work for a company that does good for animals, the world, and its people,” said Mary. “This, along with the supportive culture and great colleagues, really helps me bring my best self to work each and every day.” Learn more about Mary here.
Dr. Kevin Esch Named Zoetis’ Working Father of the Year
Zoetis named Dr. Kevin Esch, D.V.M., M.P.H., Ph.D., Dipl. ACVP, its 2023 Working Father of the Year. After working as a veterinarian in private practice for several years, Kevin joined Zoetis in 2014 as a pathologist in Veterinary Medical Research and Development. Since then, he has held various leadership roles, most currently as Executive Director of Global Pharmacokinetics, Dynamics, Metabolism and Safety. A father to daughters, Gabriella, 18, Eva, 16 and Vivienne, 11, two of Kevin’s children have Ehlers Danlos Syndrome, a spectrum of chronic connective tissue disorders that requires an endless schedule of appointments in addition to an already busy schedule. “It would be impossible to manage a career and family without a true partnership with my wife Staci, whose sacrifices and coordination in managing these medical challenges is amazing,” said Kevin. Kevin also believes that his parenting experience has made him a more empathetic leader. “As leaders, we can all continue to improve our ability to meet our colleagues where they are -- in their roles, at a stage in a project, or on a particular day. More than anything, my experience parenting has helped me gain an understanding, at work and at home, of how to determine what is truly important, and where I should focus my energy,” he said. Learn more about Kevin here.
Learn More
For more information about Zoetis, including career opportunities and our supportive and award-winning culture, visit https://www.zoetis.com/join-us. Learn more about the power of our purpose here.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.
About Seramount
Seramount is a strategic professional services and research firm dedicated to supporting high-performing, inclusive workplaces. Over four decades, we've established a strong, data-driven understanding of the employee experience, which lays the groundwork for everything we do. Seramount partners with over 450 of the world’s most influential companies, large and small, to offer pragmatic solutions including best practice DEI research, workplace assessment, employee learning and development, and talent sourcing. These offerings empower companies to navigate a dynamic corporate environment and to cultivate a resilient, connected workforce that achieves extraordinary outcomes.
Last Trade: | US$164.80 |
Daily Change: | 1.28 0.78 |
Daily Volume: | 3,068,538 |
Market Cap: | US$74.350B |
November 04, 2024 September 26, 2024 August 06, 2024 May 02, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB